保留Retzius间隙的机器人辅助腹腔镜下根治性前列腺切除术治疗早期前列腺癌(附手术视频)

Retzius-sparing robot-assisted laparoscopic radical prostatectomy for early-stage prostate cancer(with video)

目的:探讨保留Retzius间隙的机器人辅助腹腔镜下根治性前列腺切除术的初步应用。方法:2016年9~10月,入组早期前列腺癌10例,实施保留Retzius间隙的机器人辅助腹腔镜下根治性前列腺切除术。结果:10例手术均获成功,手术切缘均为阴性。完成手术时间170~250(196±25)min,术中出血量150~500(260±128)ml,术后住院日6~7 d,术后拔除导尿管时间14 d,仅1例患者存在尿失禁(每天1块尿垫),术后1个月完全恢复。结论:保留Retzius间隙的机器人辅助腹腔镜下根治性前列腺切除术安全、有效、可靠,有利于早期恢复控尿。

Objective ： To investigate the application of Retzius-sparing robot-assisted radical prostatectomy （RS-RARP） in the treatment of early-stage prostate cancer. Methods ： We retrospectively analyzed the clinical data about 10 cases of early-stage prostate cancer treated by RS-RARP with the Da Vinci Robot Surgical System from September to October 2016. Results： All the operations were successfully completed without positive surgical margins. The operation time was 170 -250 min （ [ 196 ± 25 ] rain）, the intraop- erative blood ].oss was 150 - 500 ml （ [260 ± 128 ] ml）, the postoperative hospital stay was 6 -7 days, and the catheterization time was 14 days. Urinary continence occurred after catheter removal in 1 patient and was recovered 1 month later. Conclusion ： RS-RARP is a safe, effective and reliable method for the treatment of prostate cancer and conducive to the early recovery of urinary continence.